The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / I•••••

T••••••• S••••• Capital Partners Portfolio Company B••••••••• Acquires I•••••, LLC

Add-on acquisitionclosedadd-onannounced Jul 13, 2015closed Jul 13, 2015Fact
What happened
Target
I•••••
Platform
B•••••••••add-on basis: T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company B••••••••• has acquired Chestertown, Maryland-based I•••••, a commercial biobank and molecular laboratory established to accelerate research and discovery.
Control
Control
Share acquired
unknown
Industry
healthcare / laborator
Target location
MD, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • R••••• C•••••• D•••Deal partnerconfirmed
    “Bob D•••, Managing Director of TSCP said, “I••••• enhances the B••••••••• range by providing a wide array of specimen types, including matched sets of normal and diseased tissue, FFPE, blood, and serum, focusing primarily on cancer.””
  • B•••••••••Platformconfirmed
    “T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company B••••••••• has acquired Chestertown, Maryland-based I•••••, a commercial biobank and molecular laboratory established to accelerate research and discovery.”
  • T••••••• S••••• C•••••• M•••••• L••Sponsorconfirmed
    “T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company B••••••••• has acquired Chestertown, Maryland-based I•••••, a commercial biobank and molecular laboratory established to accelerate research and discovery.”
Side not stated
  • I•••••Targetconfirmed
    “T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company B••••••••• has acquired Chestertown, Maryland-based I•••••, a commercial biobank and molecular laboratory established to accelerate research and discovery.”
Evidence
“T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that its portfolio company B••••••••• has acquired Chestertown, Maryland-based I•••••, a commercial biobank and molecular laboratory established to accelerate research and discovery.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026